NDC 73535-208 – Monjuvi

Tafasitamab 200 mg/5mL · Injection, Powder, Lyophilized, For Solution · Intravenous

Human Prescription Drug

Product NDC73535-208

Product details

Brand name
Monjuvi
Generic name
Tafasitamab-cxix
Labeler
Incyte Corporation
Dosage form
Injection, Powder, Lyophilized, For Solution
Route
Intravenous
Marketing category
BLA · BLA761163
Marketed since
August 5, 2020
Listing expires
December 31, 2027

Active ingredients

Uses, dosage, side effects and warnings for Monjuvi →

Package NDC codes (1)

Package NDCDescriptionSince
73535-208-011 VIAL in 1 CARTON (73535-208-01) / 5 mL in 1 VIALAug 5, 2020

Other Monjuvi products